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Nanoparticle use has increased radically raising concern about possible adverse effects in humans. Zinc oxide nanoparticles 
(ZnO NPs) are among the most common nanomaterials in consumer and medical products. Several studies indicate 
problems with their safe use. The aim of our study was to see at which levels ZnO NPs start to produce adverse cytogenetic 
effects in human lymphocytes as an early attempt toward establishing safety limits for ZnO NP exposure in humans. We 
assessed the genotoxic effects of low ZnO NP concentrations (1.0, 2.5, 5, and 7.5 µg mL-1) in lymphocyte cultures over 
14 days of exposure. We also tested whether low and high-density lymphocytes differed in their ability to accumulate 
ZnO NPs in these experimental conditions. Primary DNA damage (measured with the alkaline comet assay) increased 
with nanoparticle concentration in unseparated and high density lymphocytes. The same happened with the fragmentation 
of TP53 (measured with the comet-FISH). Nanoparticle accumulation was significant only with the two highest 
concentrations, regardless of lymphocyte density. High-density lymphocytes had significantly more intracellular Zn2+ 
than light-density ones. Our results suggest that exposure to ZnO NPs in concentrations above 5 µg mL-1 increases 
cytogenetic damage and intracellular Zn2+ levels in lymphocytes.
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Nanotechnology has penetrated every segment of 
human life. Its ever growing presence has raised concern 
over the health risks it may be posing (1). The existing 
approaches to risk assessment have been challenged by new 
nanoparticles that can reach otherwise inaccessible 
biological structures and induce unexpected biological 
behaviour due to their small size and large surface area. For 
example, nanoparticles can both stimulate and suppress the 
immune system (2).
Among the most common nanomaterials in consumer 
and medical products are zinc oxide nanoparticles (ZnO 
NPs). They are widely used as drug delivery vehicles, 
anticancer agents, components of the restorative dental and 
food packaging materials, and as cosmetic, antiseptic, and 
ultraviolet protection products (3, 4). Exposure to ZnO NPs 
has come into focus with recent reports that their use may 
result in safety issues. Research in vitro has demonstrated 
dose-dependent cytotoxic effects of ZnO NPs in mouse 
neural cells, mouse ascites cells, and human epithelial lung/
bronchus (5), liver (6), cardiac microvascular endothelial 
(7), and kidney cells (8). These toxic effects were mediated 
by oxidative stress and inflammation induced by ZnO NPs, 
which had stimulated the release of pro-inflammatory 
cytokines IL-6 and TNF-α.
Oxidative stress and inflammation have also been 
observed in animal models. Ma-Hock et al. (9) reported 
toxic effects of inhaled ZnO NPs on the respiratory 
epithelium in rats. Wang et al. (10) reported a dose-
dependent increase in acute cytotoxic effects on the 
stomach, liver, heart, and spleen tissues of orally treated 
mice. Zhao et al. (11) reported ZnO NPs developmental 
toxicity in embryo-larval zebrafish. So far, however, safety 
limits for human exposure to ZnO NPs have not been 
proposed.
Recently, there have been attempts to assess the risk of 
genotoxicity posed by nanomaterials with the comet assay 
(12, 13). Considering that ZnO NPs have been reported to 
adversely affect lymphocytes (14), white blood cells seem 
a model of choice for testing nanoparticle genotoxicity. In 
our study we opted for human lymphocyte cultures to see 
whether 14-day exposure to increasing concentrations of 
ZnO NPs would produce genotoxic effects and whether 
they would be concentration-dependent. We also wanted to 
see whether lymphocytes differed in their capacity to 
accumulate zinc after exposure to the same concentration 
of ZnO NPs. To do that we took a new approach that 
combines voltammetry to measure intracellular exposure 
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with the methods measuring effects: the alkaline assay to 
determine general DNA damage and the comet-FISH assays 
to determine specific effects on the structural integrity and 
copy number of the TP53 gene.
MATERIALS AND METHODS
By exposing lymphocyte cultures to different ZnO NP 
levels over 14 days we ensured that the cells would be 
exposed in all the phases of the cell cycle, which makes 
possible the direct contact between the genome and NPs. 
This is because certain types of NPs can interact with the 
DNA only during mitosis, when the nuclear membrane 
breaks down. Therefore, the extended exposure ensured 
maximum access to the genetic material (15), simulating 
exposure conditions in vivo.
We used the alkaline comet assay to determine the 
primary DNA damage in the lymphocytes. To identify 
specific effects on structural integrity and determine the 
number of the TP53 gene copies and the corresponding 
centromeres on chromosome 17 we used the comet-
fluorescence in situ hybridisation (comet-FISH) assay. The 
TP53 gene product plays an important role in cell-cycle 
regulation, leading to its arrest as a response to DNA 
damage. Too much irreparable genome damage triggers the 
TP53-dependant pathway of apoptosis. The loss of the TP53 
gene, which is a known tumour suppressor gene, indicates 
increased risk of cancer development (16).
To determine ZnO accumulation we measured the 
effective levels of ZnO that penetrated cellular membrane 
by determining the levels of Zn2+ in treated cells with 
differential pulse anodic stripping voltammetry (DPASV) 
and high-resolution inductively coupled plasma mass 
spectrometry (HR-ICPMS). Anodic stripping voltammetry 
is the most widely used method for the estimation of metals 
in a variety of matrices. Its advantages are sensitivity 
[elements can be measured at part per trillion (ppt) 
concentrations], simultaneous determination of several 
elements, capability to distinguish between oxidation states 
of atomic ions, and usefulness for speciation studies (17). 
HR-ICPMS offers several other benefits. It is a highly 
sensitive method for most elements. Both major and trace 
elements can be detected simultaneously. HR-ICPMS can 
easily handle simple and complex sample matrices. It has 
extremely low detection limits, ranging from part per billion 
(ppb) to ppt. Despite the advantages of ICP sources 
compared to other ionisation sources, the analytical 
precision is limited by inherent instability of the ion signal 
and sample introduction devices. Instabilities may arise 
from either a change in energy transfer from the plasma to 
the sample or variation efficiency in the nebulisation and 
transportation of the sample (18).
ZnO nanoparticle preparation
Zinc oxide nanoparticles (ZnO NPs) with average 
particle size <35 nm were purchased from Sigma-Aldrich 
(St. Louis, MO, USA). To obtain treatment solution under 
aseptic conditions, the ZnO NP stock solution (50 wt. % in 
water) was further diluted in phosphate buffer solution 
(PBS), pH 7.4 (Sigma-Aldrich). Before each treatment, this 
solution was sonicated for 20 minutes to ensure dispersion 
and prevent deagglomeration and reagglomeration (19).
Blood sampling and lymphocyte collection
Peripheral blood was taken from a healthy male non-
smoker donor aged 26 years with no history of chronic 
conditions. The blood was collected from the antecubital 
vein in heparin-coated vacutainers (Becton Dickenson, New 
Jersey, NJ, USA). We opted for the single-donor design to 
avoid donor variations in response and scattering of the 
results. The procedure was reviewed and approved by the 
ethics committee of the Institute for Medical Research and 
Occupational Health, and the donor gave his consent in 
writing.
Lymphocytes were isolated, and their in vitro cultures 
established following the procedure described elsewhere 
(20).
Culture treatment
Duplicate samples of lymphocyte cultures were 
incubated in a 5 % CO2 HeraCell
® 240 incubator (Kendro 
Laboratory Products, Vienna, Austria) at 37 °C for 14 days 
with solutions containing 1.0, 2.5, 5, or 7.5 µg mL-1 of ZnO 
NPs. We based this concentration choice on our preliminary 
experiments (data not shown). Negative control was treated 
with PBS. Positive control was treated with 8 µg mL-1 
methyl methanesulphonate (MMS; Sigma-Aldrich) for the 
last 4 h of incubation. Figure 1 shows a detailed treatment 
algorithm along with the study design.
Viability testing
To determine cell viability, the lymphocytes were 
simultaneously stained with acridine orange and ethidium 
bromide (Sigma-Aldrich), 100 mg mL-1 of each (v/v 1:1), 
and analysed with a epifluorescence microscope Olympus 
BX 51 (Olympus, Tokyo, Japan) under 600× magnification. 
Hundred cells per each duplicate slide were counted to 
determine the percentages of viable, apoptotic, and necrotic 
cells (21).
Experimental design
We took two routes to assess primary DNA damage 
(Figure 1). The first was to collect the entire lymphocyte 
culture population treated with ZnO NPs on the 15th day. 
The cultures were centrifuged at 300 g for 5 min, and the 
cells washed twice in a fresh culture medium (RPMI 1640, 
Gibco, Paisley, UK). The resulting lymphocyte pellet was 
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Alkaline comet assay
For the alkaline comet assay we followed the procedure 
described by Singh et al. (22) with minor modifications. 
After a 15-minute denaturation followed electrophoresis at 
0.7 V cm-1 and 300 mA for another 15 min. After 
electrophoresis, the slides were neutralised and stained with 
ethidium bromide. Scoring included 100 comets per each 
duplicate slide using the Comet Assay IV image analysis 
system (Perceptive Instruments, Suffolk, UK) coupled with 
epifluorescence microscope (Olympus BX 51) under 200× 
magnification. We looked for tail length and the percentage 
of DNA in tail (tail intensity) as the main DNA damage 
parameters.
Comet-FISH assay
The slides for the comet-FISH assay were processed 
according to the protocol described by Mladinić and 
Želježić (23). After electrophoresis and neutralisation, the 
slides were dehydrated in an ethanol series (70-100 %) and 
air dried. For each treatment we analysed 30 cells on each 
of the two duplicate slides using an Olympus AX70 
diluted in saline (0.3 mL; 0.9 % NaCl w/w) and cell density 
determined. One microlitre of suspension containing 104 
lymphocytes was mixed with 100 µL of 0.5 % low melting 
point agarose (Sigma-Aldrich) and placed on a precoated 
slide to prepare the microgels for the alkaline comet assay.
The second route was to collect lymphocyte cultures 
on day 15 (as in the first), centrifuge them at 300 g for 5 min, 
wash once and resuspend in RPMI 1640 (3 mL), layer on 
the Histopaque® 1077 reagent (3 mL, Sigma-Aldrich), and 
centrifuge at 400 g for 30 min to isolate lymphocytes. 
Isolation resulted in the separation of two lymphocyte 
populations. The low-density population formed a ring in 
the isolation medium, while the high-density population 
pelleted at the bottom of the tube (Figure 1). Each 
population was extracted separately, washed twice in RPMI 
1640, and diluted in saline (0.3 mL). The slides for the 
comet assay were prepared according to the standard 
procedure (22). For each ZnO NP concentration tested, as 
well as for negative and positive controls we prepared four 
slides. Two were used for the alkaline comet assay and the 
other two for the comet-FISH assay.
Figure 1 Scheme of the experimental design
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epifluorescence microscope and CytoVision FISH software 
(Applied Imaging, Dornach, Germany). We recorded the 
position of the signals for the TP53 gene and cen 17 in 
nucleoids and the number of copies. Then we scored the 
number of signals in the comet tail and head. The absence 
of the signals from both tail and head was considered a loss 
of heterozygosity (20).
DPASV and HR-ICPMS analysis of lymphocyte Zn2+ 
concentration
All chemicals used for the preparation of the samples 
were of high purity: ASTM type I ultra-pure water (Milli-Q; 
18.2 MΩ cm, Millipore/Merck, Darmstadt, Germany), 
Trace SELECT® concentrated HNO3 (Fluka, Milan, Italy), 
and sodium-acetate (NaAc; Merck). Aliquots of lymphocytes 
obtained as described above (Figure 1) were washed two 
more times in saline, centrifuged at 300 g for 5 min, and 
the pellet was resuspended in saline to obtain the final cell 
concentration of 105 cells mL-1. Lymphocyte suspension 
(15 mL) was acidified with ultra-pure HNO3 (150 µL; Trace 
SELECT®, Fluka) and left to rest overnight. The samples 
were then transferred to fluorinated ethylene propylene 
(FEP) bottles and UV-irradiated under a 250 W high-
pressure Hg-lamp for another 24 h for the organic matter 
to decompose and transform all dissolved Zn into a 
specimen that can be measured with DPASV. As the working 
volume of the electrochemical cell used in DPASV is 
15 mL, we needed to dilute the sample (~15 mL), so that 
it would not be used up for one analysis. The solution for 
the measurement was prepared by taking an aliquot of 
undiluted primary sample, adding 0.5 mL of 4 mol L-1 
NaAc) to adjust pH around 4, and adding Milli-Q water to 
fill up the 15 mL volume. The blank sample containing 
HNO3, NaAc, and Milli-Q water used for sample preparation 
was measured separately and found to contain 0.11 ng mL-1 
of Zn2+, most of which came from Milli-Q water. We 
therefore corrected our Zn2+ measurements in treated/
control samples for the blank measurement, as we followed 
the same dilution procedure for all samples.
The concentration of Zn2+ was measured with DPASV 
as described by Vukosav et al. (24). Accumulation time was 
1 min, and accumulation potential was -1.2 V. Figure 2 
shows a typical set of the obtained voltammograms and the 
corresponding calibration plot (inset). For the measurement 
signal we used the peak Zn2+ voltammogram that we 
transformed using the 2nd derivative transformation (25). 
For Zn2+control measurements we used the semi-
quantitative HR-ICPMS (Element 2, Thermo Fisher 
Scientific, Bremen, Germany) (26).
Statistical analysis
Prior to statistical analysis we normalised all data ranges 
using base 10 log transformation. Differences in comet 
assay parameters and Zn2+ concentrations in lymphocytes 
were tested with the one-way ANOVA. The same method 
was used for low- and high-density lymphocytes. We also 
used the one-way ANOVA to test the differences in 
measured Zn2+ concentrations between DPASV and HR-
ICPMS. To test the dependence of each cytogenetic 
endpoint on intracellular Zn2+ concentration and on ZnO 
concentration used in the treatment we used regression 
analysis. This method was also used to assess the correlation 
between the treatment ZnO NP concentrations and 
intracellular Zn2+ concentrations (determined with DPASV). 
All analyses were run on Statistica 12.0 software (StatSoft, 
Tulsa, OK, USA).
Figure 2 Typical DPAS voltammograms of Zn2+ levels following the Tube 2,5, 5x standard addition method with a threefold dilution. 
Inset: standard addition plot from which Zn concentration was determined
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RESULTS
Zinc concentrations in treated lymphocytes
The 14-day treatment of lymphocyte cultures with ZnO 
NPs in the concentrations of 2.5, 5, and 7.5 µg mL-1 resulted 
in the separation of the lymphocytes into two populations 
of cells according to their relative density (Figure 3). Low-
density lymphocytes formed a ring in Histopaque®, while 
high-density cells settled at the bottom, forming a pellet. 
This separation was not observed at ZnO NP concentration 
of 1 µg mL-1 or in negative control samples, all of which 
formed a ring. Even though the separation started with 
2.5 µg mL-1, the differences in intracellular Zn2+ 
concentrations between high-density cells and negative 
control or low-density cells were not significant 
(37.2±0.0 ng 10-5 cells vs. 13.8±4.9 ng 10-5 cells or vs. 
19.5±1.7 ng 10-5 cells, respectively).
The accumulation of intracellular Zn2+ became 
significant with exposure to 5.0 and 7.5 µg mL-1 of ZnO 
NPs. In low-density lymphocytes it was significantly higher 
than in negative control (47.1±1.4 and 149.2±7.3 ng 10-5 
cells, respectively), and in high-density lymphocytes it was 
significantly higher than in both negative control and low-
density lymphocytes (207.2±3.4 and 430.2±8.1 ng 10-5 cells, 
respectively).
Both DPASV and HR-ICPMS used for the determination 
of intracellular Zn2+ levels showed very consistent and 
reproducible results over the entire range of concentrations 
and their values did not significantly differ (Figure 4). 
However, we considered the DPASV results more accurate.
Regression analysis showed a significant correlation 
between the applied ZnO NP concentrations and DPASV 
intracellular Zn2+ measurements.
Cell viability
Significant differences in the number of apoptotic cells 
started to show at 5 µg mL-1, but only between high-density 
and negative control lymphocytes. This difference increased 
at 7.5 µg mL-1 and also became significant between high-
density and low-density lymphocytes (Table 1).
Alkaline comet assay
We found no significant differences in the tail length and 
intensity between the unseparated ZnO NP-treated and 
negative control cells (first route; Table 2). In the separated 
cells, similar results were observed for low-density 
lymphocytes, except for tail intensity in the cells treated with 
5 µg mL-1 of ZnO NPs, which increased significantly. High-
density lymphocytes treated with the highest concentrations 
of ZnO NPs (5 and 7.5 µg mL-1) had significantly greater tail 
length and intensity than negative control. Similar was the 
difference from low-density lymphocytes at 5 µg mL-1, except 
for the tail length (Table 2).
Regression analysis showed a significant correlation 
between both the ZnO NP and Zn2+ concentrations and the 
comet tail length.
Comet-FISH analysis
Table 3 shows the fragmentation and deletion rate of 
the TP53 gene and the corresponding chromosome 17 
centromere. In the unseparated lymphocytes, a significant 
increase in TP53 fragmentation was observed in samples 
treated with 2.5, 5, and 7.5 µg mL-1 of ZnO NPs compared 
to negative controls. ZnO NP treatment did not cause the 
loss of TP53 heterozygosity.
In low-density lymphocytes significant TP53 
fragmentation was detected only in the sample exposed to 
7.5 µg mL-1 of ZnO NPs.
The structural integrity of the TP53 gene was more 
impaired in the high-density lymphocytes. Treatment with 
ZnO NPs concentrations of 2.5, 5, and 7.5 µg mL-1 resulted 
in significantly higher occurrence of TP53 signals in the 
comet tail compared to negative controls. Fragmentation 
rates in high-density lymphocytes exposed to 2.5 and 
5 µg mL-1 were also significantly higher than in low-density 
lymphocytes. The percentage of the fragmented centromere 
17 copies in high-density cells became significantly higher 
only at 5 µg mL-1 but not at 7.5 µg mL-1. We observed no 
significant differences in the deletion of the TP53 copies 
between the treated and untreated or high and low-density 
groups.
Regression analysis showed a significant correlation 
between both the ZnO NP and Zn2+ concentrations and 
impaired structural integrity of the TP53 gene (Table 3).
DISCUSSION
Our study is the first to investigate nanoparticle 
genotoxicity in lymphocyte populations separated by 
density due to different uptake of ZnO NPs. Unlike earlier 
studies (15, 27, 28), which used whole lymphocyte 
populations, ours is a novel approach that compares the 
effects of ZnO NPs by combining DPASV and HR-ICPMS 
with two comet assays.
The added value of our study was the testing of 
extended-term lymphocyte cultures instead of acute testing. 
By implementing this approach we ensured that the cells 
were exposed to ZnO NPs throughout the cell cycle, which 
makes possible the direct contact between genome and NPs.
Extended exposure to ZnO NPs led to significantly 
different results between the two approaches. When the 
unseparated lymphocytes were evaluated for viability, we 
found no significant differences between the treated and 
control cells, regardless of the concentration used (Table 
1), but in the separated populations these differences became 
significant at concentrations above 5 µg mL-1, and the 
proportion of apoptotic cells was significantly higher in 
high-density lymphocytes.
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Table1 Results of ethidium bromide/acridine orange staining of lymphocyte cultures treated with ZnO NPs for 14 days




1 91.5±3.5 8.0±2.8 0.5±0.7
2.5 90.0±1.4 8.5±2.1 1.5±0.7
5 92.5±0.7 7.0±1.4 0.5±0.7
7.5 88.0±2.8 8.5±2.1 3.5±0.7
Negative control 93.0±1.4 7.0±1.4 0.0±0.0
Positive control 74.6±5.11 19.5±3.41 5.9±1.7
Low-density lymphocytes 
separated in Histopaque®
1 88.5±0.7 11.5±0.7 0.0±0.0
2.5 91.0±1.4 7.5±0.7 1.5±0.7
5 89.0±1.4 10.0±2.8 1.0±1.4
7.5 90.0±4.2 8.0±4.2 2.0±0.0
Negative control 91.5±2.1 8.0±1.4 0.5±0.7
Positive control 73.4±2.11 21.9±4.01 4.7±0.8
High-density lymphocytes 
separated in Histopaque®
1 - - -
2.5 87.5±0.7 8.5±3.5 4.5±2.1
5 82.0±1.41 16.0±1.41 2.0±0.0
7.5 76.5±2.11,2 20.0±7.11,2 3.5±4.9
Negative control - - -
Positive control - - -
1statistically significant compared to negative control; 2statistically significant compared to low-density cells. Null values mean that 
there were no high-density cells in the isolation medium, only low-density ones
Table 2 Results of the alkaline comet assay in lymphocyte cultures treated with ZnO NPs for 14 days










Negative control 24.5±1.9 0.9±1.2







Negative control 26.2±2.4 0.9±1.2







Negative control - -
Positive control - -
1statistically significant compared to negative control; 2statistically significant compared to low-density cells. Null values mean that 
there were no high-density cells in the isolation medium, only low-density ones
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Using DPASV and HR-ICPMS we clearly established 
that intracellular Zn2+ content in high-density cells was 
significantly higher than in both negative control and low-
density cells exposed to the same ZnO NP concentrations 
(Figure 3) and that higher accumulation of Zn2+ triggered 
a greater cytotoxic effect. These findings correspond to the 
observations reviewed by Ivask et al. (27). Kim et al. (28) 
reported that ZnO NPs hindered mitochondrial function in 
rat alveolar epithelial cells in vitro by impairing 
transmembrane electron transport through increased inner 
membrane permeability. They also suggested that it was 
Zn+2 released from nanoparticles that contributed to the 
induction of oxidative stress. Sharma et al. (6) also proposed 
extensive reactive oxygen species formation as a contributor 
to apoptosis in a HepG2 cell line exposed to ZnO 
nanoparticles for 12 h. The exact mechanism of ZnO 
cytotoxicity, however, remains to be determined. Guo et al. 
(29) suggest that ZnO NPs trigger cell death by activating 
caspase-12 and by reducing the levels of caspase-9 and 
bcl-2 at the same time.
Differences in the observed ZnO NP cytotoxicity 
between our two approaches could be attributed to the 
composition of the lymphocyte suspensions used for 
viability testing. The lymphocyte population used in the 
first approach (without separation) contained cells which 
took up different amounts of ZnO NPs. Another important 
factor which might significantly affect both cyto- and 
genotoxicity findings are the intracellular concentrations of 
Zn2+ ions released from NPs. They might also vary between 
single cells, which further complicates the interpretation of 
our results.
Nevertheless, if the interpretation of the results were 
based only on the first approach, this could lead to a wrong 
conclusion, as no one could estimate the ratios between 
high and low-density cells or the extent of the oxidative 
stress which might have been caused by Zn2+ accumulation 
in individual cells. In other words, our results in these mixed 
populations might underestimate the real cyto- or 
genotoxicity caused by the treatment.
The advantage of the second approach (with separation) 
allowed us to distinguish between low-density lymphocytes, 
which exhibited lower cytotoxicity and accumulated lower 
amounts of ZnO and high-density ones.
Regardless of the separation, our study has shown that 
a significant increase in primary DNA damage started with 
exposure to 5 µg mL-1 of ZnO NPs (Table 1). Mu et al. (30) 
provided evidence on Zn release from ZnO NPs administered 
in the concentrations below 5.5 µg mL-1. The level of 
dissolution they observed correlated with genome damage 
induced in different epithelial cell lines measured with the 
alkaline comet assay. Similar results have been reported by 
Demir et al. (31) for ZnO NPs of 50-80 nm in diameter. 
They detected genotoxic effects (specifically, oxidised bases 
in DNA) in human embryonic kidney fibroblasts and mouse 
embryonic fibroblasts at concentrations above 10 µg mL-1. 
Zinc oxide NPs are capable of inducing primary DNA 
damage in many other human cell models in vitro: human 
epidermal cells (32), cervix carcinoma Hep-2 cells (33), 
bronchial epithelial BEAS-2B cells (34), epidermal 
keratinocytes (35), nasal mucosa cells (36), liver HepG2 
cells (37), and hepatocytes (38). All these models showed 
dose-related effects on comet assay parameters. Our study 
confirms this dose-response relationship: tail length 
significantly correlated with ZnO NPs concentrations and 
intercellular Zn2+ concentrations. The difference, however, 
is that the cited studies evaluated genome damage induced 
by acute exposure, while ours measured the effects of 
longer-term exposure in lymphocytes separated by density, 
Figure 3 Average Zn2+ concentrations in lymphocyte cultures treated with ZnO NPs for 14 days determined with the differential pulse 
anodic stripping voltammetry (DPASV) and high resolution inductively plasma mass spectrometry (HR-ICPMS).asignificantly different 
from negative control; b significantly different from low-density lymphocytes (p<0.05)
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most likely due to different ZnO NPs uptake. In addition, 
the comet-FISH assay has revealed that ZnO NPs at 
concentrations above 2.5 µg mL-1 are capable of 
compromising primary DNA integrity (Table 3) in an 
intracellular concentration-dependent manner. The presence 
of ZnO NPs in cells may impair TP53 transcription. This 
impairment makes the cells more susceptible to genotoxic 
effect (39).
We found a significant correlation between TP53 
fragmentation (primary damage) and both intracellular Zn2+ 
concentration and general primary DNA damage. It seems 
that the genotoxic action of ZnO NPs per se or via ROS 
induction randomly targets various genome regions rather 
than specific sites.
Genome integrity, and therefore functionality, was 
significantly affected by ZnO NPs in a concentration-
dependent manner. This dependence, however, was not clear 
between the loss of TP53 copies loss and the applied ZnO 
or intracellular Zn2+ concentrations.
Considering that the frequency of TP53 deletions 
showed a limited and insignificant correlation with the 
frequency of TP53 fragmentation, it is possible that the 
damage accumulated in the gene locus may be related to a 
later loss of gene copies, but this has to be studied further. 
This also suggests that gene fragmentation rate may be 
considered as a biomarker of exposure, while the deletion 
frequency should rather be considered as a biomarker of 
effect. Together with previous report by Ng et al. (40), who 
claim that an effective response to the genotoxic potential 
of ZnO NPs greatly depends on the integrity of the TP53 
gene, our findings speak in favour of exposure to ZnO NPs 
as a possible cancer risk factor.
Our approach based on the separation of two lymphocyte 
populations by density at treatment concentrations above 
2.5 µg mL-1 and determination of intracellular Zn2+ with 
DPASV and HR-ICPMS showed that there was a significant 
difference in the uptake rate of ZnO NPs between 
lymphocytes. Gilbert et al. (41) have already evidenced that 
ZnO NPs enter cells undissolved. Particles are taken up 
through endocytosis, primarily via caveolae, and end up in 
intracellular vesicles (42). Once ZnO enters the cell, it tends 
to dissolve in aqueous media and convert to its biologically 
active form Zn2+ (43). Unlike caveolae, lysosomes contain 
zinc only in its ionic form, most likely due to their acidic 
content, which facilitates the dissolution of ZnO. Cytosolic 
zinc mostly binds to metalloproteins. Another route for Zn2+ 
uptake from extracellular environment to the cytosol is 
mediated by Zrt/Irt-like transmembrane proteins (44).
Our regression analysis has shown a strong correlation 
between ZnO concentrations and intracellular Zn2+ levels, 
especially at concentrations above 5 µg mL-1. Differences 
in intracellular Zn2+ levels resulted in the separation of the 
lymphocytes by density, which allowed us to separately 
study the toxic effects in low and high-density populations. 
Table 3 Comet-FISH assay-determined fragmentation and deletion of the TP53 gene and centromere of chromosome 17 in lymphocyte 





Fragmented copies Deleted copies
TP53 gene Cen 17 TP53 gene Cen 17
(mean %±SD) (mean %±SD) (mean %±SD) (mean %±SD)
Unseparated 
lymphocytes
1 21.5±11.8 3.4±4.7 3.3±0.0 3.4±2.3
2.5 36.6±4.71 27.5±3.51 4.2±1.2 0.0±0.0
5 40.0±4.71 21.6±2.3 3.8±0.6 0.8±1.2
7.5 35.0±7.11 13.4±9.4 4.2±1.2 1.7±0.0
Negative control 13.3±0.0 5.0±2.4 2.5±1.1 0.8±1.2





1 15.0±2.4 3.3±4.7 3.3±0.0 3.3±2.3
2.5 18.3±2.4 11.7±7.1 5.0±2.4 1.7±2.4
5 20.0±4.7 16.7±0.0 5.0±2.4 2.5±3.5
7.5 35.0±7.11 18.3±2.4 6.7±0.0 2.5±1.2
Negative control 13.3±0.0 5.0±2.4 2.5±1.1 0.8±1.2





1 - - - -
2.5 38.3±11.81,2 18.3±2.4 5.8±1.2 2.5±3.5
5 48.3±2.41,2 25.0±11.81 5.0±0.0 3.3±0.0
7.5 48.3±2.41 21.7±2.4 5.8±1.8 3.3±4.7
Negative control - - - -
Positive control - - - -
1statistically significant compared to negative control; 2statistically significant compared to low-density cells. Null values mean that 
there were no high-density cells in the isolation medium, only low-density ones
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This approach provided additional statistical power to the 
correlation analysis, whose aim was to test the relation 
between primary DNA lesions, loss of TP53 integrity and 
heterozigocity, and intracellular Zn2+ concentrations. 
Differences in zinc accumulation between cultured cells of 
the same population have already been reported by Yoo et 
al. (45). The authors were reluctant to attribute them to the 
variations in molecular mechanisms involved in the 
endocytosis of NPs or to transmembrane zinc transporters 
but rather to the differences in relative surface charge of 
the nanoparticles. Cells take up positively charged ZnO 
NPs more efficiently. This explanation, however, does not 
apply for our study, because all our lymphocytes were 
exposed to the same nanoparticles and the ratio of positively 
charged particles should not vary within one culture. The 
differentiation rather suggests that there are differences in 
accumulation capacity between lymphocytes at ZnO NP 
concentrations above 2.5 µg mL-1. As already mentioned, 
there are several pathways of Zn uptake in the cell, but there 
is a single way out: via the Zn2+/H+ transporter ZnT-1. Yu 
et al. (46) reported that in human lung epithelial cells 
intracellular accumulation plateaued at ZnO levels ten times 
higher than used in our study due to the saturation of the 
uptake mechanisms. Our results suggest that high-density 
lymphocytes accumulated higher intracellular Zn2+ content 
with increasing concentrations of ZnO NPs. This finding 
suggests that mechanisms responsible for Zn2+ extrusion 
get saturated as early as 2.5 µg mL-1, judging by significantly 
higher intracellular zinc concentrations compared to 
corresponding low-density lymphocytes (Figure 3).
The value of the comet assay in genotoxicity evaluation 
of materials with unknown biocompatibility was previously 
confirmed by Galić et al. (47). The three main parameters 
most commonly used to quantify DNA damage in the comet 
assay are the tail length, tail intensity, and tail moment (48). 
In our study, we assessed both tail length and tail intensity, 
and the obtained results suggest that they both adequately 
reflected the level of primary DNA damage. However, many 
literature sources consider tail intensity as more sensitive, 
especially at intense genotoxic events when the tail length 
reaches its maximum and plateaus (49). If ZnO can induce 
biologically significant primary DNA lesions that would 
become mutations or chromosome aberrations, tail intensity 
should exhibit a higher correlation to intracellular Zn2+ than 
tail length. We, however, observed the opposite. Tail length 
and TP53 fragmentation correlated with intracellular Zn 
concentrations, while tail intensity did not. Even so, all 
highly depended on the migration of the DNA in the electric 
field during electrophoresis. The only endpoint that did not 
depend on electrophoresis was the deletion of TP53. It also 
did not significantly correlate either with ZnO NPs or Zn2+.
All things considered, this study has not clarified the 
issue of the applicability of the comet assay as a widely 
used technique for assessing the risk of novel nanomaterials. 
As discussed earlier, ZnO NPs dissociate within the cell, 
which results in an increase in free intracellular Zn2+. This 
ionic form of zinc is responsible for the observed adverse 
effects of ZnO in the cells. As a negatively charged 
macromolecule, DNA is an ideal target to released Zn2+. 
These interactions may result in various types of primary 
DNA damage that are converted by alkaline electrophoresis 
into additional DNA breaks, which can be visualised and 
measured with the comet assay. Therefore, understanding 
Zn2+/DNA interactions and their behaviour in the electric 
field is crucial for accurate interpretation of the obtained 
results.
The biological relevance of the obtained results strongly 
depends on accurate interpretation of the comet assays. In 
the electric field, denaturated DNA migrates toward the 
positively charged anode, while complexed Zn2+ would 
Figure 4 Comparison of Zn2+ concentrations measured with the differential pulse anodic stripping voltammetry (DPASV) and high 
resolution inductively plasma mass spectrometry (HR-ICMS)
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migrate to the negatively charged cathode. The question 
remains whether and how complexed Zn2+ ions interfere 
with the ability of damaged DNA to migrate. Does the 
observed genotoxicity originate from biological interaction 
between Zn2+ and DNA in situ or is it an artefact resulting 
from the assay’s limitations? Would complexed Zn2+ impair 
gene expression and stability in situ, or is it a consequence 
of exposing the complexed DNA to the electric field when 
Zn2+ induces strand breaks? It is difficult to answer this 
question, considering that most studies reported positive 
results of the alkaline comet assay but did not find oxidative 
DNA damage following exposure to NPs. As previous 
studies point, there are discrepancies between the endpoints 
that depend on comet assay electrophoresis and classical 
cytogenetic biomarkers (12). In designing protocols for the 
risk assessment of NP interactions with biological systems 
we should be aware of the concerns raised by Karlsson (12) 
and Doak et al. (50) that NPs may interfere with the comet 
assay outcomes. In spite of these limitations, our study has 
shown that combining electrochemical with genotoxicity 
methods can help to evaluate the cyto/genotoxicity of ZnO 
NPs, but further studies are needed to elucidate their toxicity 
profile.
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Alternativni pristup mjerenju koncentracije nanočestica ZnO u kulturama humanih limfocita - spoj 
elektrokemije i testova genotoksičnosti
S naglim porastom primjene nanočestica raste i mogućnost njihova štetna djelovanja u ljudi. Nanočestice cinkova oksida 
najčešći su oblik nanomaterijala u potrošačkim proizvodima i lijekovima. Nekoliko je istraživanja već upozorilo na 
probleme vezane uz njihovu sigurnu primjenu. Cilj je ovoga istraživanja bio utvrditi pri kojim razinama nanočestice ZnO 
počinju štetno citogenetski djelovati na humane limfocite i time otvoriti pitanje utvrđivanja graničnih razina za sigurnu 
primjenu nanočestica ZnO u ljudi. Stoga smo istražili genotoksične učinke niskih koncentracija nanočestica ZnO (1,0; 
2,5; 5 i 7,5 µg mL-1) izloživši kulture humanih limfocita njihovu djelovanju tijekom 14 dana. Uz to smo izmjerili razlikuju 
li se limfociti niske gustoće od onih visoke gustoće u sposobnosti akumuliranja nanočestica ZnO pri istim eksperimentalnim 
uvjetima. Primarno oštećenje DNA (izmjereno alkalnim komet-testom) povećalo se s rastom koncentracije nanočestica 
u limfocitima koje nismo razdvojili po gustoći te u limfocitima visoke gustoće. Slično smo povećanje zamijetili s 
fragmentacijom tumorskoga supresorskoga gena TP53 (izmjereno komet-FISH testom). Nakupljanje Zn2+ iona u stanicama 
bilo je značajno samo kod primjene dviju najviših koncentracija nanočestica ZnO, bez obzira na gustoću limfocita. Osim 
toga, limfociti visoke gustoće iskazali su i značajno više razine unutarstaničnoga Zn2+ od limfocita niske gustoće. Naši 
rezultati upozoravaju na to da se izlaganjem razinama nanočestica ZnO višima od 5 µg mL-1 značajno povisuju razine 
Zn2+ u limfocitima te se povećava oštećenje tih stanica i njihova genoma.
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48. Rojas E, Lopez MC, Valverde M. Single cell electrophoresis 
assay: methodology and applications. J Chrom B Biomed 
Sci Appl 1999;722:225-54. doi: 10.1016/S0378-
4347(98)00313-2
49. Collins AR, Oscoz AA, Brunborg G, Gaivao I, Giovannelli 
L, Kruszewski M, Smith CC, Stetina R. The comet assay: 
topical issues. Mutagenesis 2008;23:143-51. doi: 10.1093/
mutage/gem051
50. Doak S, Griffiths S, Manshian B, Singh N, Williams P, Brown 
A, Jenkins G. Confounding experimental considerations in 
nanogenotoxicology. Mutagenesis 2009;24:285-93. doi: 
10.1093/mutage/gep010
